Novartis Investigative Site

Roskilde, Denmark DK-4000

0 studies enrolling now · 2 studies all time

What they study most

Cardiovascular Disease, Chronic Obstructive Pulmonary Disease, Type 2 Diabetes Mellitus

Studies at this site

• Aliskiren Trial in Type 2 Diabetes Using Cardiovascular and Renal Disease Endpoints (Core and Extension Phases) — Stopped early
• Effect of QVA149 Versus NVA237 and Tiotropium on Chronic Obstructive Pulmonary Disorder (COPD) Exacerbations — Completed